Global sale process of Nature's Care

Client	Nature's Care
Industry	Pharmaceutical manufacturing
Services provided	Receivership, stabilisation and sale of a business via a global M&A process

 

BDO was engaged in the receivership of a Nature’s Care pharmaceutical manufacturing business, following a breakdown in shareholder relations and the expiry of significant debt facilities. The shareholder agreement restricted the sale of all shares, making a solvent sale process unviable and triggering the need for an insolvency-led restructuring.

The engagement was initiated to regain control, stabilise operations, and prepare the business for sale under distressed conditions.

We provided business restructuring services, including:

• Receivership and business stabilisation
• Financial and operational review
• Cashflow management
• Global M&A process coordination
• Sell-side financial and tax due diligence
• Business recovery and turnaround advisory.

Strategy and restructuring path

Our approach included implementing a multi-phase restructuring strategy:

• Appointing receivers to holding companies to establish governance control
• Stabilising measures including key management changes, cashflow oversight, and enhanced reporting
• Appointing a global investment bank to lead the international M&A process
• Supporting the transaction via sell-side financial and tax due diligence
• Collaborating with the sale adviser, legal counsel, and senior secured lenders to ensure alignment and transparency.

Outcome

The restructuring and sale process resulted in:

• Successful sale of the operating companies
• Lenders repaid in full
• All employees retained, preserving jobs and operational continuity
• Unsecured and statutory creditors paid in the ordinary course of business.